Rhinosinusitis

from Wikipedia, the free encyclopedia
Classification according to ICD-10
J01.- Acute sinusitis
J32.- Chronic sinusitis
ICD-10 online (WHO version 2019)

A rhinosinusitis is a simultaneous inflammation of the nasal mucosa ( " rhinitis ") and inflammation of the mucosa of the paranasal sinuses ( " sinusitis "). A distinction is made between acute rhinosinusitis and chronic rhinosinusitis (CRS).

background

Sinusitis is usually preceded by inflammation of the nasal mucous membrane, so that some authors suggest replacing the term “sinusitis” with “rhinosinusitis” in general. This is also supported by the fact that the mucous membrane of the paranasal sinuses and the nose form a functional unit. A distinction is made between acute and chronic rhinosinusitis. Acute rhinosinusitis has a disease duration of a maximum of 12 weeks. The clinical picture of acute rhinosinusitis is characterized by purulent nasal secretion, nasal obstruction and / or pressure headache or a feeling of fullness in the facial area. Acute rhinosinusitis can be viral or bacterial - a differentiation is not possible in the first few days. If the clinical picture is characterized by a two-stage course, this indicates a bacterial rhinosinusitis. Chronic rhinosinusitis is when the disease lasts more than 12 weeks and does not result in complete recovery. The symptoms of chronic rhinosinusitis are less pronounced compared to acute rhinosinusitis. Chronic rhinosinusitis is characterized by impaired nasal breathing, a feeling of pressure and swelling in the facial area and an increased susceptibility to infection.

Serious complications are rare, but orbital and intracranial inflammation can occur.

therapy

The inhalation therapy mechanically removed deposits and contributes to allergic or inflammatory diseases such as acute and chronic rhinosinusitis (CRS) for the relief of discomforts associated with - in short, it eliminates the by the patient as a nuisance perceived obstruction , relieves irritation of the nasal mucosa and helps the self-cleaning. Inhalation therapy has found its expression in North American and international guidelines for the treatment of CRS (Bachmann et al., 2000). Acute rhinosinusitis is treated with different approaches. You can choose from analgesics for pain, decongestant nasal drops or nasal sprays for local decongestion, topical nasal steroids, phytotherapeutic agents and, in the case of bacterial rhinosinusitis, antibiotics are used .

See also

Individual evidence

  1. ↑ AWMF register number 053-012 (status: February 1, 2008 - in revision); valid until February 1, 2013; Classification: S3 guideline for rhinosinusitis . In: AWMF online
  2. ↑ Boris A. Stuck et al .: AWMF register number 017-049 (status: March 1, 2011 in revision); valid until February 29, 2016; Classification: S2k guidelines for rhinosinusitis . In: AWMF online
  3. ↑ "short version of the guideline 017-049". (pdf) (No longer available online.) In: AWMF . Archived from the original on May 28, 2016 ; accessed on October 16, 2016 .
  4. ↑ "Long version of the guideline 017-049". (pdf) (No longer available online.) In: AWMF . Archived from the original on July 5, 2016 ; accessed on October 16, 2016 .